Want to see AZR full AI Analyst Report?
Azora Therapeutics (AZR) Stock Statistics & Valuation Metrics
Total Valuation
Azora Therapeutics has a market cap or net worth of $10.00M. The enterprise value is $45.46M.
- Market Cap
- $10.00M
- Enterprise Value
- $45.46M
Share Statistics
Azora Therapeutics has 2,625,890 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 2,625,890
- Owned by Insiders
- 30.04%
- Owned by Institutions
- 0.95%
Financial Efficiency
Azora Therapeutics’s return on equity (ROE) is -1.51 and return on invested capital (ROIC) is -144.40%.
- Return on Equity (ROE)
- -1.51
- Return on Assets (ROA)
- -1.17
- Return on Invested Capital (ROIC)
- -144.40%
- Return on Capital Employed (ROCE)
- -1.44
- Revenue Per Employee
- 0
- Profits Per Employee
- -1.33M
- Employee Count
- 6
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Azora Therapeutics is -0.31. Azora Therapeutics’s PEG ratio is 0.01.
- PE Ratio
- -0.31
- PS Ratio
- 0.00
- PB Ratio
- 149.61
- Price to FCF
- -1.19
- Price to Operating Cash Flow
- -2.10
- PEG Ratio
- 0.01
Income Statement
In the last 12 months, Azora Therapeutics had revenue of 0 and earned -7.98M in profits. Earnings per share was -11.93.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -7.80M
- Pretax Income
- -7.98M
- Net Income
- -7.98M
- EBITDA
- -7.98M
- Earnings Per Share (EPS)
- -11.93
Cash Flow
In the last 12 months, operating cash flow was -11.13M and capital expenditures -1, giving a free cash flow of -11.13M billion.
- Operating Cash Flow
- -11.13M
- Free Cash Flow
- -11.13M
- Free Cash Flow per Share
- -2.41
Dividends & Yields
Azora Therapeutics pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -83.95%
- Earnings Yield
- -247.65%
Stock Price Statistics
- Beta
- 1.44
- 52-Week Price Change
- -57.27%
- 50-Day Moving Average
- 4.71
- 200-Day Moving Average
- 3.19
- Relative Strength Index (RSI)
- 46.48
- Average Volume (3m)
- 58.76K
Important Dates
Azora Therapeutics upcoming earnings date is Nov 18, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 17, 2026
- Next Earnings Date
- Nov 18, 2026
- Ex-Dividend Date
- ―
Financial Position
Azora Therapeutics as a current ratio of 4.42, with Debt / Equity ratio of 0.00%
- Current Ratio
- 4.42
- Quick Ratio
- 4.42
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.74
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Azora Therapeutics has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Azora Therapeutics EV to EBITDA ratio is 0.27, with an EV/FCF ratio of 1.39.
- EV to Sales
- 0.00
- EV to EBITDA
- 0.27
- EV to Free Cash Flow
- 1.39
- EV to Operating Cash Flow
- 1.39
Balance Sheet
Azora Therapeutics has $28.71M in cash and marketable securities with $0.00 in debt, giving a net cash position of $28.71M billion.
- Cash & Marketable Securities
- $28.71M
- Total Debt
- $0.00
- Net Cash
- $28.71M
- Net Cash Per Share
- $10.93
- Tangible Book Value Per Share
- $0.03
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Azora Therapeutics is $12.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $12.50
- Price Target Upside
- 228.08% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 3
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 45.78%
Scores
- Smart Score
- ―
- AI Score
- 42
